PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24431397-4	2015	CK2 signalling was inhibited by the selective CK2 inhibitor 4, 5, 6, 7-Tetrabromobenzotriazole (TBB).	4,5,6,7-tetrabromobenzotriazole	60-94	casein kinase 2, alpha prime polypeptide	Mus musculus	0-3	
26623569-4	2016	The results showed that both CK2 inhibitors, 4,5,6,7-tetrabromobenzotriazole (TBB) and quinalizarin, markedly reduced the toxicity of Zn(ii), Al(iii), Co(ii), Cr(vi) and As(iii).	4,5,6,7-tetrabromobenzotriazole	45-76	casein kinase 2, alpha prime polypeptide	Mus musculus	29-32	
26623569-4	2016	The results showed that both CK2 inhibitors, 4,5,6,7-tetrabromobenzotriazole (TBB) and quinalizarin, markedly reduced the toxicity of Zn(ii), Al(iii), Co(ii), Cr(vi) and As(iii).	4,5,6,7-tetrabromobenzotriazole	78-81	casein kinase 2, alpha prime polypeptide	Mus musculus	29-32	
27001465-7	2016	CK2 inhibitor 4,5,6,7-Tetrabromobenzotriazole (TBB) significantly retarded the growth of glioma xenografts in athymic nude mouse model.	4,5,6,7-tetrabromobenzotriazole	14-45	casein kinase 2, alpha prime polypeptide	Mus musculus	0-3	
27001465-7	2016	CK2 inhibitor 4,5,6,7-Tetrabromobenzotriazole (TBB) significantly retarded the growth of glioma xenografts in athymic nude mouse model.	4,5,6,7-tetrabromobenzotriazole	47-50	casein kinase 2, alpha prime polypeptide	Mus musculus	0-3	
24431397-4	2015	CK2 signalling was inhibited by the selective CK2 inhibitor 4, 5, 6, 7-Tetrabromobenzotriazole (TBB).	4,5,6,7-tetrabromobenzotriazole	60-94	casein kinase 2, alpha prime polypeptide	Mus musculus	46-49	
18308722-4	2008	In Ussing chamber experiments with mouse airways, colon, and cultured M1-collecting duct cells, amiloride-sensitive Na(+) transport was inhibited dose-dependently by the selective CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB).	4,5,6,7-tetrabromobenzotriazole	194-225	casein kinase 2, alpha prime polypeptide	Mus musculus	180-183	
22768244-7	2012	4,5,6,7-tetrabromobenzotriazole (TBB), a CK2-specific inhibitor, attenuated ER stress-induced XBP-1 splicing and subsequent induction of GRP78 expression, but was ineffective against ER stress-induced eIF2alpha phosphorylation and CHOP expression.	4,5,6,7-tetrabromobenzotriazole	0-31	casein kinase 2, alpha prime polypeptide	Mus musculus	41-44	
22768244-7	2012	4,5,6,7-tetrabromobenzotriazole (TBB), a CK2-specific inhibitor, attenuated ER stress-induced XBP-1 splicing and subsequent induction of GRP78 expression, but was ineffective against ER stress-induced eIF2alpha phosphorylation and CHOP expression.	4,5,6,7-tetrabromobenzotriazole	33-36	casein kinase 2, alpha prime polypeptide	Mus musculus	41-44	
18662771-5	2008	Tyrosine phosphorylation of CK2 in cells and in CK2 immunoprecipitates is dependent on CK2 activity and is inhibited by the CK2 selective inhibitor 4,5,6,7-tetrabromobenzotriazole.	4,5,6,7-tetrabromobenzotriazole	148-179	casein kinase 2, alpha prime polypeptide	Mus musculus	28-31	
18662771-5	2008	Tyrosine phosphorylation of CK2 in cells and in CK2 immunoprecipitates is dependent on CK2 activity and is inhibited by the CK2 selective inhibitor 4,5,6,7-tetrabromobenzotriazole.	4,5,6,7-tetrabromobenzotriazole	148-179	casein kinase 2, alpha prime polypeptide	Mus musculus	48-51	
18662771-5	2008	Tyrosine phosphorylation of CK2 in cells and in CK2 immunoprecipitates is dependent on CK2 activity and is inhibited by the CK2 selective inhibitor 4,5,6,7-tetrabromobenzotriazole.	4,5,6,7-tetrabromobenzotriazole	148-179	casein kinase 2, alpha prime polypeptide	Mus musculus	48-51	
18662771-5	2008	Tyrosine phosphorylation of CK2 in cells and in CK2 immunoprecipitates is dependent on CK2 activity and is inhibited by the CK2 selective inhibitor 4,5,6,7-tetrabromobenzotriazole.	4,5,6,7-tetrabromobenzotriazole	148-179	casein kinase 2, alpha prime polypeptide	Mus musculus	48-51	
18691077-7	2008	Both endpoints were significantly reduced by the CK2 inhibitors 4,5,6,7-tetrabromobenzotriazole (TBB) and 2-dimethyl-amino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT), and by the PKC inhibitor GF109203X; the PI3K inhibitors LY294002 and wortmannin had no effect.	4,5,6,7-tetrabromobenzotriazole	64-95	casein kinase 2, alpha prime polypeptide	Mus musculus	49-52	
18691077-7	2008	Both endpoints were significantly reduced by the CK2 inhibitors 4,5,6,7-tetrabromobenzotriazole (TBB) and 2-dimethyl-amino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT), and by the PKC inhibitor GF109203X; the PI3K inhibitors LY294002 and wortmannin had no effect.	4,5,6,7-tetrabromobenzotriazole	97-100	casein kinase 2, alpha prime polypeptide	Mus musculus	49-52	
18308722-4	2008	In Ussing chamber experiments with mouse airways, colon, and cultured M1-collecting duct cells, amiloride-sensitive Na(+) transport was inhibited dose-dependently by the selective CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB).	4,5,6,7-tetrabromobenzotriazole	227-230	casein kinase 2, alpha prime polypeptide	Mus musculus	180-183	
15836981-5	2005	Our first studies focused on the ability of the selective CK2 inhibitors 4,5,6,7-tetrabromobenzotriazole (TBBT) and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) to reduce formalin-stimulated pain behaviors in mice.	4,5,6,7-tetrabromobenzotriazole	73-104	casein kinase 2, alpha prime polypeptide	Mus musculus	58-61	
15836981-5	2005	Our first studies focused on the ability of the selective CK2 inhibitors 4,5,6,7-tetrabromobenzotriazole (TBBT) and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) to reduce formalin-stimulated pain behaviors in mice.	4,5,6,7-tetrabromobenzotriazole	106-110	casein kinase 2, alpha prime polypeptide	Mus musculus	58-61